Utilization of cornstarch in glycogen storage disease type Ia
Olaf A. Bodamer(Broad Institute), James V. Leonard(University College London), Marjorie Dixon(Great Ormond Street Hospital for Children NHS Foundation Trust), François Feillet(Hôpital d'Enfants), Rebecca Lane(Harefield Hospital), Philip Lee, D. Halliday(St Mary's Hospital)
Cited by 25
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326
Phenylketonuria Scientific Review Conference: State of the science and future research needs
|Molecular Genetics and Metabolism|2014|271